Clinical Trial Update: Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating erlotinib (Tarceva) with or without apatinib in advanced lung adenocarcinoma. The status of the trial is not reported in the p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• Tarceva (erlotinib)

Snippet

Sponsor: First Affiliated Hospital of Kunming Medical University | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN